Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma

Malignant pleural mesothelioma is a notoriously chemoresistant tumour. However, a recent single institution study showed an impressive activity of gemcitabine and cisplatin. Our aim is to investigate the efficacy and toxicity of a gemcitabine and cisplatin combination in selected and chemo-naive pat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: van Haarst, J M W, Baas, P, Manegold, C h, Schouwink, J H, Burgers, J A, de Bruin, H G, Mooi, W J, van Klaveren, R J, de Jonge, M J A, van Meerbeeck, J P
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2002
Gaiak:
Clinical
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375227/
https://ncbi.nlm.nih.gov/pubmed/11875695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600118
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak